Tissue microarray analysis of cyclin-dependent kinase inhibitors p21 and p16 in Fuchs dystrophy.
Tissue microarray analysis of cyclin-dependent kinase inhibitors p21 and p16 in Fuchs dystrophy.
复制标题
DOI:
10.1097/ico.0b013e31826f324e
复制
发表时间:
2013-04
期刊:
影响因子:
2.8
通讯作者:
Jun AS
中科院分区:
文献类型:
--
作者:
Matthaei M;Lackner EM;Meng H;Hicks JL;Meeker AK;Eberhart CG;Jun AS
To investigate the novel application of tissue microarray (TMA) technology to corneal disease and to report altered protein expression of senescence-associated cyclin-dependent kinase inhibitors p21 and p16 in Fuchs endothelial corneal dystrophy (FECD). A TMA including 208 cores was generated from paraffin-embedded tissues including corneal buttons of 50 FECD and 5 keratoconus (KC) patients retrieved post penetrating keratoplasty, 10 autopsy globes with non-pathologic corneas, and non-ocular control specimens. TMA sections were immunolabeled for p21 and p16 and analyzed using a nine-grade scoring system (0–8). Result validation was performed by immunolabeling of individual whole tissue sections. Corneal endothelial p21 and p16 expression levels in FECD specimens compared to controls served as main outcome measures. TMA immunohistochemical analysis disclosed increased endothelial expression levels of nuclear p21 in FECD specimens (p<0.05) and an altered endothelial p16 expression pattern. Immunolabeling of whole tissue sections showed statistically significant endothelial overexpres-sion of both proteins (p21 and p16, p<0.05). The present study introduces TMA technology as a valuable tool for molecular high-throughput profiling of corneal tissues. It demonstrates p21 and p16 overexpression in the corneal endothelium of genetically undifferentiated FECD patients supporting a role of cellular senescence in the pathogenesis of FECD.